nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
June 03, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Results of 2024 Annual General Meeting
May 31, 2024 17:01 ET | Mainz BioMed NV
Mainz Biomed Reports Results of 2024 Annual General Meeting
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
May 28, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
May 20, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
May 07, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
April 25, 2024 09:29 ET | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Full Year 2023 Financial Results
April 09, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Reports Full Year 2023 Financial Results
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
March 19, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
nasdaq-mynz-mainzbiomed.png
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
March 18, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
March 12, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations